Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The nasal microbiome modulates risk for SARS-CoV-2 infection

EBioMedicine(2025)10.1016/j.ebiom.2025.105660Source: DataRank Database

The nasal microbiome modulates risk for SARS-CoV-2 infection is a research paper published in EBioMedicine (2025). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 4.10)OA: goldTopics (46)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Maliha Aziz ORCID,Juan E. Salazar ORCID,Tony Pham ORCID,Sydney G. Nelson,Jack Villani ORCID

Live enrichment

PubMed:40210576 PMC:PMC12143206 OpenAlex:https://openalex.org/W4409287108

National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases

Grant: R01AI168182

George Washington University

National Institutes of Health

Milken Institute School of Public Health, George Washington University

National Institute of Allergy and Infectious Diseases

FWCI

4.10

Citation Percentile

0.9%

Citation Trend

2025

2026

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.ebiom.2025.105660

publisherhttps://doi.org/10.1016/j.ebiom.2025.105660

publisherhttps://api.elsevier.com/content/article/PII:S2352396425001045?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2352396425001045?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40210576

Fields of Study

Sinusitis and nasal conditionsRespiratory viral infections researchSARS-CoV-2 detection and testing

MeSH Terms

Angiotensin-Converting Enzyme 2COVID-19SARS-CoV-2AdultAgedCross-Sectional StudiesFemaleHumansMaleMiddle AgedNasal CavityNasal MucosaRetrospective StudiesRNA, Ribosomal, 16SSerine EndopeptidasesCase-Control StudiesMicrobiota

Keywords

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MicrobiomeCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakBetacoronavirusVirologySars virusCoronavirus InfectionsMedicineImmunologyBiologyBioinformaticsDiseasePathologyOutbreakInfectious disease (medical specialty)Staphylococcus aureusAdultsHaemophilus influenzaeACE2Moraxella catarrhalisTmprss2Nasal MicrobiomeCovid-19Sars-cov-2Dolosigranulum Pigrum

The nasal microbiome modulates risk for SARS-CoV-2 infection

FAIR Checklist

Authors (10)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)